Sargent Bickham Lagudis’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$63.4K	Hold	483	–	–	0.01%	398
2022 Q3	$56K	Sell	483 -47	-9%	-$5.45K	0.01%	391
2022 Q2	$62K	Sell	530 -2	-0.4%	-$234	0.01%	381
2022 Q1	$69K	Hold	532	–	–	0.01%	393
2021 Q4	$81K	Hold	532	–	–	0.01%	368
2021 Q3	$86K	Hold	532	–	–	0.01%	356
2021 Q2	$87K	Hold	532	–	–	0.01%	360
2021 Q1	$80K	Hold	532	–	–	0.01%	360
2020 Q4	$81K	Hold	532	–	–	0.01%	355
2020 Q3	$72K	Sell	532 -75	-12%	-$10.2K	0.01%	337
2020 Q2	$83K	Hold	607	–	–	0.01%	296
2020 Q1	$65K	Sell	607 -155	-20%	-$16.6K	0.01%	304
2019 Q4	$92K	Hold	762	–	–	0.01%	290
2019 Q3	$76K	Hold	762	–	–	0.01%	286
2019 Q2	$83K	Sell	762 -300	-28%	-$32.7K	0.01%	301
2019 Q1	$119K	Hold	1,062	–	–	0.01%	263
2018 Q4	$102K	Sell	1,062 -309	-23%	-$29.7K	0.01%	268
2018 Q3	$167K	Sell	1,371 -444	-24%	-$54.1K	0.02%	223
2018 Q2	$199K	Hold	1,815	–	–	0.02%	200
2018 Q1	$194K	Buy	1,815 +63	+4%	+$6.73K	0.02%	209
2017 Q4	$187K	Sell	1,752 -153	-8%	-$16.3K	0.02%	226
2017 Q3	$212K	Sell	1,905 -6	-0.3%	-$668	0.03%	212
2017 Q2	$198K	Sell	1,911 -216	-10%	-$22.4K	0.03%	207
2017 Q1	$208K	Sell	2,127 -354	-14%	-$34.6K	0.03%	203
2016 Q4	$220K	Buy	2,481 +3	+0.1%	+$266	0.03%	191
2016 Q3	$239	Sell	2,478 -135	-5%	-$13	0.04%	192
2016 Q2	$224K	Sell	2,613 -1,581	-38%	-$136K	0.03%	191
2016 Q1	$365K	Buy	+4,194	New	+$365K	0.06%	155